Hope Biosciences Research Foundation

This study tested the safety of giving stem cells through an IV to 10 people aged 76-95 with Parkinson's disease. The treatment involved multiple infusions over 18 weeks, using the patients' own stored stem cells. The goal was to see if this approach is safe, not to cure the dise…

This study gave a single patient with severe cerebral palsy eight infusions of their own fat-derived stem cells. The goal was to see if this treatment could improve their quality of life after all standard options had failed. The approach uses the patient's own banked stem cells,…

This study tests the safety and early effects of using a patient's own stored stem cells to treat chronic inflammatory demyelinating polyneuropathy (CIDP), a rare nerve disorder. Only one patient who has banked their stem cells at the sponsor's facility can join. The treatment in…

This study offers expanded access to a stem cell treatment for people with long-term spinal cord injuries. It uses the patient's own fat cells to try to restore nerve signals and feeling. The goal is to improve movement and quality of life, but it is not a cure and requires ongoi…

This study provides an 84-year-old man who had a severe ischemic stroke with access to an experimental treatment using his own stem cells (HB-adMSCs). The goal is to see if the treatment is safe and may help control the damage from the stroke. The patient received the cells after…

This study aimed to test whether stem cell infusions could safely improve symptoms in children with juvenile idiopathic arthritis. It was designed for 66 participants aged 2 to 17, but the trial was withdrawn before any patients were enrolled. The main focus was on safety and sym…

This study gave 14 intravenous infusions of the patient's own banked stem cells to a single child with a rare, severe form of congenital muscular dystrophy caused by a LMNA gene mutation. The goal was to see if the treatment is safe and can help control the disease. Because the c…

This program offers multiple intravenous infusions of a patient's own stem cells (HB-adMSCs) to up to 11 people with Parkinson's disease who were not chosen for a related Phase 2 study. The goal is to see if the treatment is safe and can help control symptoms. It is not a cure, b…

This study provides an experimental stem cell treatment (HB-adMSCs) to one 83-year-old man with Primary Lateral Sclerosis, a rare nerve disease that causes progressive muscle weakness. The goal is to see if the treatment can slow the disease when standard drugs have failed. The p…

This study provides expanded access to an experimental stem cell treatment called HB-adMSCs for people with systemic lupus erythematosus (SLE). It is designed for individual patients who have their own stem cells banked at Hope Biosciences. The goal is to evaluate safety and how …

This study tests a new stem cell treatment (HB-adMSCs) for people with relapsing-remitting multiple sclerosis (RRMS). The goal is to see if multiple infusions of the patient's own stem cells can improve quality of life and reduce disability. Ten adults who previously received a p…

This was a special access program for one patient with ALS (Lou Gehrig's disease). The patient received 10 infusions of their own specially grown stem cells over 18 weeks. The goal was to see if these cells could help slow the disease and improve the patient's function and qualit…

This study tested a stem cell treatment for a 58-year-old man with nerve damage caused by POEMS syndrome. He received eight infusions of his own stem cells over 28 weeks to help relieve symptoms. The study is no longer available and only included one person.

This trial gave a single patient multiple infusions of stem cells (HB-adMSCs) to treat long-term muscle and joint pain. The goal was to reduce pain and improve quality of life over about 32 weeks. The study is no longer available.

This study tested a stem cell treatment in one person with long-term knee pain from osteoarthritis who had no other options left. The patient received stem cells from their own fat, given through a vein and directly into both knees. The goal was to see if it is safe and if it can…

This study gave adults aged 18-65 with Post-COVID-19 Syndrome (long COVID) access to an experimental stem cell treatment called HB-adMSCs, added to their usual care. The goal was to see if it could safely ease lingering symptoms like fatigue or brain fog. The study is no longer a…